
McKesson (MCK) Stock Forecast & Price Target
McKesson (MCK) Analyst Ratings
Bulls say
McKesson is a strong player in the pharmaceutical distribution industry, with a focus on specialty drugs and an extensive distribution network. Challenges such as pricing pressure and supply chain disruptions have been offset by their partnerships, services, and technology solutions. The company has consistently grown adjusted EPS and plans to continue this trend through top-line growth and expense reduction.
Bears say
McKesson is facing obstacles in its RxTS segment due to constraints in medication options and drug prices, with the company being heavily reliant on the success of GLP-1 and biosimilar businesses. This could lead to a decline in revenue and margins, while potential regulatory changes and industry consolidation may also pose a threat to the company's operations. While the company plans to spin off its medical-surgical solutions segment and has a strong presence in the U.S. healthcare industry, its long-term growth and adjusted EPS may still be at risk due to current challenges in the market.
This aggregate rating is based on analysts' research of McKesson and is not a guaranteed prediction by Public.com or investment advice.
McKesson (MCK) Analyst Forecast & Price Prediction
Start investing in McKesson (MCK)
Order type
Buy in
Order amount
Est. shares
0 shares